“breast-cancer” Archives

Entry Author Date Location
This Drug Didn’t Work for Me. May I Have My $88,000 Back, Please? 06/30/11 Seattle
Genentech Shot Down at FDA Hearing on Avastin for Breast Cancer 06/29/11 San Francisco
Atossa Nabs $6.6M 06/27/11 Seattle
Hale, Royston Join Biocept Board 05/02/11 San Diego
KEW, Led by Millennium Co-Founder, Seeks to Bring Big-Time Cancer Care to Community Clinics 04/27/11 Boston
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again 03/21/11 National
ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer 02/25/11 Boston
Gilead Bets $600M on Cancer, Genentech Gets a Hearing, Jennerex Shows Early Survival Edge, & More Bay Area Life Sciences News 02/25/11 San Francisco
Genentech Gets FDA Hearing 02/24/11 San Francisco
Sanofi Buys Genzyme for $20B, Aveo Inks Deal with Astellas, Hologix Nabs FDA Approval, & More Boston-Area Life Sciences News 02/18/11 Boston
Aveo Pharma Lands $1.4B Deal with Astellas, A Few Months Ahead of Cancer Trial Result 02/16/11 Boston
Genomic Health, Taking a Hit on Bottom Line, Bets Next-Gen Sequencing Will Yield Next-Gen Diagnostics 02/15/11 San Francisco
Hologic Gets FDA Nod for 3-D Mammography 02/14/11 Boston
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41 02/10/11 Boston
NanoString, Snapping Up Genomic Health Veteran, Seeks to Prove Economic Value of Cancer Diagnostic 02/03/11 Seattle
FDA To Yank Avastin Breast Cancer Approval 12/16/10 San Francisco
Genomic Health Seeks to Build Momentum For Healthcare Shift from Rx to Dx 11/08/10 San Francisco
PacBio IPO, Not Exactly the Netscape Moment of 2010, But a Win for Genomics 10/28/10 San Francisco
Genentech’s Souped-Up Breast Cancer Drug Beats Original Herceptin in Head-to-Head Study 10/08/10 San Francisco
Cerulean Pharma Makes Progress in Attacking the Big C with Tiny Drugs 09/07/10 Boston
ImmunoGen and Genentech “Empowered Antibody” Cancer Drug Fails to Garner Accelerated Approval from FDA 08/27/10 Boston
Biocept Targets Spreading Tumors With Advance in Diagnostics 08/20/10 San Diego
Syndax Pharma Snags $6M Debt Deal 08/09/10 Boston
Genentech Fails to Sway FDA Panel 07/20/10 San Francisco
Corey Goodman’s New Startup, UCSF Spinoff Raises $40M, Gail Maderis Gives Back, & More Bay Area Life Sciences News 07/09/10 San Francisco
Genentech Seeks FDA Nod for T-DM1 07/07/10 San Francisco
On-Q-ity, Led by Former Genzyme Exec, Takes on “Diagnostic Black Hole” in Cancer 07/07/10 Boston
Tesaro: Former MedImmune CEO’s Firm Writes Check, Cancer Drug Vets Build Pipeline 06/28/10 Boston
Genentech’s Souped-Up Antibody, Reg Kelly’s Mission, LS9 Nears Moment of Truth & More Bay Area Life Sciences News 06/25/10 San Francisco
Genentech’s Souped-Up Herceptin: The Odyssey Toward a More Powerful Breast Cancer Drug 06/14/10 San Francisco
Page 3 of 4 « previous page · next page »